Daniela Tomazela is currently the Senior Director of Protein Therapeutics at Gilead Sciences, a position held since 2024. Previously, they served as the Director of Protein Therapeutics at Gilead from 2022 to 2024 and have held multiple roles in the protein sciences field, including positions at Merck and Waters Corporation. Daniela earned a PhD in Organic Chemistry with a focus on Mass Spectrometry from Universidade Estatal de Campinas and also holds a Master's degree in Organic Chemistry from UFSCar. They further enhanced their skills with project management training from the University of Washington in 2009. Throughout their career, Daniela has contributed significantly to advancements in protein therapeutics and bioanalytics.
This person is not in the org chart
This person is not in any teams
This person is not in any offices